CRANE STRATEGIES

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$5.2M

Filings

141

Unique Clients

Active Period

2012–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$260,000	4	2
2025	$480,000	8	2
2024	$400,000	8	2
2023	$480,000	10	3
2022	$560,000	12	3
2021	$560,000	12	3
2020	$450,000	12	3
2019	$420,000	13	3
2018	$240,000	8	2
2017	$240,000	8	2
2016	$240,000	8	2
2015	$220,000	8	2
2014	$200,000	8	2
2013	$225,000	10	3
2012	$200,000	12	3

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
SIGA TECHNOLOGIES	$1,950,000	58	2012–2026
ALZHEIMER'S ASSOCIATION	$1,670,000	46	2012–2023
REGENERON PHARMACEUTICALS, INC.	$1,480,000	31	2019–2026
CHILD MIND INSTITUTE	$75,000	6	2012–2013

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	134
HOUSE OF REPRESENTATIVES	129
Health & Human Services, Dept of (HHS)	119
Natl Institutes of Health (NIH)	37

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	141
Health Issues	Health Issues	2

Bills Explicitly Cited (3)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3299114th Congress

Strengthening Public Health Emergency Response Act of 2016

2016 · fourth_quarter · Client: SIGA TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

S. 2055 Medical Countermeasure Innovation Act of 2016, issues relating to Priority Review Vouchers. H.R. 6 21st Century Cures Act, issues relating to Priority Review Vouchers. H.R. 3299 Strengthening Public Health Emergency Response Act of 2015, issues relating to Priority Review Vouchers.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 3299

H.R. 6114th Congress

21st Century Cures Act

2016 · fourth_quarter · Client: SIGA TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

S. 2055 Medical Countermeasure Innovation Act of 2016, issues relating to Priority Review Vouchers. H.R. 6 21st Century Cures Act, issues relating to Priority Review Vouchers. H.R. 3299 Strengthening Public Health Emergency Response Act of 2015, issues relating to Priority Review Vouchers.

Client expense: — · Firm income: $20,000

Matched citations: H.R. 6

S. 2055114th Congress

Medical Countermeasure Innovation Act of 2016

2016 · fourth_quarter · Client: SIGA TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

S. 2055 Medical Countermeasure Innovation Act of 2016, issues relating to Priority Review Vouchers. H.R. 6 21st Century Cures Act, issues relating to Priority Review Vouchers. H.R. 3299 Strengthening Public Health Emergency Response Act of 2015, issues relating to Priority Review Vouchers.

Client expense: — · Firm income: $20,000

Matched citations: S. 2055

Source: Senate LDA

CRANE STRATEGIES — Lobbying Disclosure | Poliscope